Literature DB >> 26141334

Opioid Analgesics.

Robert N Jamison1, Jianren Mao2.   

Abstract

Chronic pain is an international health issue of immense importance that is influenced by both physical and psychological factors. Opioids are useful in treating chronic pain but have accompanying complications. It is important for clinicians to understand the basics of opioid pharmacology, the benefits and adverse effects of opioids, and related problematic issues of tolerance, dependence, and opioid-induced hyperalgesia. In this article, the role of psychiatric comorbidity and the use of validated assessment tools to identify individuals who are at the greatest risk for opioid misuse are discussed. Additionally, interventional treatment strategies for patients with chronic pain who are at risk for opioid misuse are presented. Specific behavioral interventions designed to improve adherence with prescription opioids among persons treated for chronic pain, such as frequent monitoring, periodic urine screens, opioid therapy agreements, opioid checklists, and motivational counseling, are also reviewed. Use of state-sponsored prescription drug monitoring programs is also encouraged. Areas requiring additional investigation are identified, and the future role of abuse-deterrent opioids and innovative technology in addressing issues of opioid therapy and pain are presented.
Copyright © 2015 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26141334     DOI: 10.1016/j.mayocp.2015.04.010

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  33 in total

1.  Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors.

Authors:  Joseph J Palamar; Jenni A Shearston; Eric W Dawson; Pedro Mateu-Gelabert; Danielle C Ompad
Journal:  Drug Alcohol Depend       Date:  2015-11-21       Impact factor: 4.492

2.  Evaluation and comparison of tools for diagnosing problematic prescription opioid use among chronic pain patients.

Authors:  Merav Kovatch; Daniel Feingold; Odelia Elkana; Shaul Lev-Ran
Journal:  Int J Methods Psychiatr Res       Date:  2016-10-23       Impact factor: 4.035

Review 3.  Opioid Treatment of Migraine: Risk Factors and Behavioral Issues.

Authors:  Melissa T Stone; Valerie Weed; Ronald J Kulich
Journal:  Curr Pain Headache Rep       Date:  2016-09

4.  Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats.

Authors:  Harshini Neelakantan; Erica D Holliday; Robert G Fox; Sonja J Stutz; Sandra D Comer; Margaret Haney; Noelle C Anastasio; F Gerard Moeller; Kathryn A Cunningham
Journal:  ACS Chem Neurosci       Date:  2017-02-13       Impact factor: 4.418

Review 5.  Current Strategies for the Management of Painful Diabetic Neuropathy.

Authors:  Michael D Staudt; Tarun Prabhala; Breanna L Sheldon; Nicholas Quaranta; Michael Zakher; Ravneet Bhullar; Julie G Pilitsis; Charles E Argoff
Journal:  J Diabetes Sci Technol       Date:  2020-08-28

6.  Sublingual desmopressin is efficient and safe in the therapy of lithiasic renal colic.

Authors:  Catalin Pricop; Dumitru D Branisteanu; Martha Orsolya; Dragos Puia; Anca Matei; Ionel Alexandru Checherita
Journal:  Int Urol Nephrol       Date:  2015-12-16       Impact factor: 2.370

7.  The cannabinoid CB2 receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence.

Authors:  Vishakh Iyer; Richard A Slivicki; Ana C Thomaz; Jonathon D Crystal; Ken Mackie; Andrea G Hohmann
Journal:  Eur J Pharmacol       Date:  2020-09-05       Impact factor: 4.432

8.  Incidence of Chronic Opioid Use in Previously Opioid-Naïve Patients Receiving Opioids for Analgesia in the Intensive Care Unit.

Authors:  Mohammad Q Adil; Austin De La Cruz; J Douglas Thornton; Matthew A Wanat
Journal:  Fed Pract       Date:  2020-04

9.  PA-Int5: An isatin-thiosemicarbazone derivative that exhibits anti-nociceptive and anti-inflammatory effects in Swiss mice.

Authors:  Aldilane Gonçalves Da Fonseca; Luzia Leiros De Sena Fernandes Ribeiro Dantas; Joquebede Pereira Rodrigues; Marco Polo Da Costa Alencar Filho; Moacyr Jesus Barreto De Melo Rêgo; Maira Galdino Da Rocha Pitta; Paulo André Teixeira De Moraes Gomes; Vanessa Gouveia De Melo Silva; Ana Cristina Lima Leite; Allanny Alves Furtado; Matheus De Freitas Fernandes Pedrosa; Elaine Cristina Gavioli; Telma Maria Araújo Moura Lemos
Journal:  Biomed Rep       Date:  2021-05-26

10.  Fecal microbiota transplantation and antibiotic treatment attenuate naloxone-precipitated opioid withdrawal in morphine-dependent mice.

Authors:  Ana C Thomaz; Vishakh Iyer; Taylor J Woodward; Andrea G Hohmann
Journal:  Exp Neurol       Date:  2021-06-18       Impact factor: 5.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.